EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Case Report: Reversible myelodysplastic syndrome secondary to sodium valproate in an epileptic child

Hongyu Huang, Jiao Chen, Lei Ye, Dan Yu

Frontiers in Pediatrics · 17.06.2026 · 14

DOI: 10.3389/fped.2026.1828816 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Pediatrics, online erschienen am 17.06.2026. Verfasst von Hongyu Huang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, WCSUH-Tianfu, Sichuan Provincial Children's Hospital, Meishan, China. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We report a rare case of sodium valproate (VPA)-induced reversible myelodysplastic syndrome (MDS) in an Asian child with epilepsy, thus expanding the recognition of VPA-associated hematological toxicity. Although VPA has been widely used, the reversibility of MDS as a complication remains underreported, particularly in pediatric populations. Case summary A 9-year-old boy with epilepsy developed pancytopenia (hemoglobin level: 77 g/L, platelet count: 83 × 10 9 /L) and bone marrow-confirmed MDS after 6 months of VPA therapy. Following a reduction in VPA dose to 250 mg/day with adjunctive lacosamide, hematological parameters normalized within 3 months, and a repeat bone marrow examination revealed resolution of dysplastic features. Seizure control was maintained without relapse. This case highlights the dose-dependent nature of VPA-induced MDS and demonstrates its reversibility upon therapeutic intervention.

Conclusion

The reversibility of VPA-induced MDS following dose adjustment underscores the importance of vigilant hematological monitoring in children.

Schlagwörter

Stichwörter der Autor:innen

case reportchildrenepilepsymyelodysplastic syndromereversiblesodium valproate

Autor:innen und Institutionen

  • Department of Pediatrics, WCSUH-Tianfu, Sichuan Provincial Children's Hospital, Meishan, China.
  • Department of Nursing, West China Second University Hospital, Sichuan University, Chengdu, China.
  • Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Sichuan University, Chengdu, China.
  • Department of Laboratory Medicine, West China Second University Hospital, Sichuan University, Chengdu, China.
  • Department of Medical Genetics, West China Second University Hospital, Sichuan University, Chengdu, China.

Zitieren

APA

Huang, H., Chen, J., Ye, L., & Yu, D. (2026). Case Report: Reversible myelodysplastic syndrome secondary to sodium valproate in an epileptic child. Frontiers in Pediatrics, 14. https://doi.org/10.3389/fped.2026.1828816

Vancouver

Huang H, Chen J, Ye L, Yu D. Case Report: Reversible myelodysplastic syndrome secondary to sodium valproate in an epileptic child. Frontiers in Pediatrics. 2026;14. doi:10.3389/fped.2026.1828816

BibTeX
@article{Huang2026,
  author = {Huang, Hongyu and Chen, Jiao and Ye, Lei and Yu, Dan},
  title = {Case Report: Reversible myelodysplastic syndrome secondary to sodium valproate in an epileptic child},
  journal = {Frontiers in Pediatrics},
  year = {2026},
  volume = {14},
  doi = {10.3389/fped.2026.1828816}
}
Kostenlos starten →